Clinigene deploys SAS Clinical Data Management solution to accelerate clinical research

January 7, 2010 – SAS, the leader in business analytics software and services, today announced that Clinigene International Limited, a full-service Clinical Research Organization that partners with global pharmaceutical and biotechnology companies, has deployed SAS Clinical Data Management - PheedIt solution to accelerate clinical research. SAS PheedIt is a highly efficient, cost effective and easy-to-use clinical data management solution (CDMS).
Mr. Manoj Yasodharan, Manager - Clinical Data Management & Biostatistics, Clinigene International Ltd said “SAS PheedIt provides a complete solution for clinical data management and analysis. We have successfully reduced the time for setup, for new trial projects. SAS partnership has helped us in setting up our own server thereby giving us complete control over the entire data management, analysis and reporting process.”
SAS is a de facto standard in the Life Science industry for statistical analysis and clinical trial reporting. SAS Clinical Data Management solution incorporates powerful Electronic Data Capture (EDC) and data management features which provide a robust data entry portal integrated with ability to handle data transformation, data imports and exports, analysis and reporting.
Mr. Sudipta K Sen, Regional Director South-East Asia, CEO & MD SAS India says “Our wealth of expertise and extensive track record positions us well as a leader in this field. This yet another win for SAS ensures our commitment as a partner to help organizations make a clear impact on their business goals.”
SAS Clinical Data Management - PheedIT comes with its own data storage thereby eliminating need for separate database. This data storage is used by the SAS PheedIT report engine to generate reports, graphs and other visualizations, and can be easily used by internal or external statisticians.

About SAS
SAS is the leader in business analytics software and services, and the largest independent vendor in the business intelligence market. With innovative business applications supported by an enterprise intelligence platform, SAS helps customers at 45,000 sites improve performance and deliver value by making better decisions faster. Since 1976 SAS has been giving customers around the world The Power to Know.

About SAS India
SAS has been in India since 1997 and has two wholly owned subsidiaries in the country: SAS Institute (India) Pvt. Ltd. and SAS Research & Development. With a team of more than 600 technology and domain experts, SAS India operations are headquartered in Mumbai with regional offices in Bangalore, New Delhi and Pune. SAS works with organizations across Industries and offers them critical enterprise intelligence to fuel innovation and meet their business objectives. Information on SAS India operations can be found at www.sas.com/india

About Clinigene India
Established in the year 2000 as a Biocon subsidiary, Clinigene International Limited is a service based Clinical Research Organization that partners with global pharmaceutical and biotechnology companies in their clinical development programs. Being India’s first CAP (College of American Pathologists) certified Central Laboratory, Clinigene is focused on quality and adds value to its clients’ clinical development programs by evolving various execution strategies to offer timely completion of deliverables, data confidentiality and cost-competitive services. Clinigene is currently undertaking over 30 clinical programs for pharmaceutical and biotechnology companies. Clinical research projects range from bioequivalence / bioavailability, early phase proof of concept studies to late phase programs facilitating registrations. In collaboration with over 160 investigators across India, Clinigene is managing clinical data for more than 4,000 patients.
Visit us at http://www.clinigeneintl.com/

Atridev Misra
Mutual PR
38A, Maha Nirbaan Road,1st Floor
Near Triangular Park, Kolkata-700029

Mobile: +91 9679620446| Website: www.mutualpr.com

This release was published on openPR.